Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Suitability Petitions topic
No spam. Unsubscribe anytime.
FDA panel: container-closure swap may not require suitability petition unless strength or total drug content changes
Summary
Panelists said switching a product from an RLD vial to a prefilled syringe does not automatically require a suitability petition if strength and total drug content remain the same; if concentration or total drug content changes, a petition is required.
An online attendee asked whether an ANDA applicant proposing to supply a generic in a different container-closure system (for example, a prefilled syringe instead of an RLD vial) must file a suitability petition.
Andrew (Agency official, S3) said the short answer is "it depends." He explained a container-closure change by itself "is not a petitionable change in a suitability petition," but if the proposed container system results in a different concentration or total drug content (a strain/strength change for injectables), a suitability petition is required before submitting an ANDA. "If your product has... the same strength and the same concentration, that would not require [a suitability petition]," Andrew said.
The guidance is specific for injectables: changes that alter total drug count or concentration are treated as a strength/strain change and trigger petition requirements. The panel encouraged applicants to seek pre-submission advice for borderline cases.
